December 23, 2022 — Electroducer, a company developing an innovative and cost-effective medical device for the treatment of heart diseases, today announces that the positive results from its pilot study have been published in the medical journal EuroIntervention. 

EuroIntervention is well regarded globally as the most prestigious European publication focused on interventional cardiology. 

December 22, 2022 — Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.

December 22, 2022 — New research findings have revealed an underlying genetic cause for why some children who have had COVID-19 infection develop Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but potentially life-threatening disease.

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias, announced the successful treatment of patients using the latest Genesis Robotic Magnetic Navigation (RMN) system by physicians of the nationally recognized Fred & Lena Meijer Heart Center, part of Corewell Healt